Long‐term follow‐up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T‐cells in follicular lymphoma patients treated by rituximab‐maintenance regimen

Authors: Laurent, Camille, Flores, Maria, Chartier, Loïc, Huet, Sarah, Bolen, Christopher R., Venstrom, Jeffrey M., Chassagne‐Clément, Catherine, Dartigues‐Cuilléres, Peggy, Charlotte, Fréderic, Tesson, Bruno, Salles, Gilles, Morschhauser, Franck, Xerri, Luc

Source: British journal of haematology. 202(3):686-689

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187933578.0x000001&indx=1&recIds=ETOCvdc_100187933578.0x000001

Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis

Authors: Sivakumar, Smruthy ^*, Lee, Jessica K ^*, Moore, Jay A, Hopkins, Julia, Newberg, Justin Y, Madison, Russell, Graf, Ryon, Schrock, Alexa B, Kobetz, Erin, Vince, Randy, Franco, Idalid, Seldon, Crystal, Frampton, Garrett M, Mills, Jennifer, Venstrom, Jeffrey ^†, Mahal, Brandon A ^{†, *}

Source: In The Lancet Digital Health June 2023 5(6):e380-e389

Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer

Authors: Graf, Ryon P., Fisher, Virginia, Mateo, Joaquin, Gjoerup, Ole V., Madison, Russell W., Raskina, Kira, Tukachinsky, Hanna, Creeden, James, Cunningham, Rachel, Huang, Richard S.P., Mata, Douglas A., Ross, Jeffrey S., Oxnard, Geoffrey R., Venstrom, Jeffrey M., Zurita, Amado J.

Source: European urology. 81(1):37-47

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154225862.0x000001&indx=1&recIds=ETOCvdc_100154225862.0x000001

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Authors: Horak, Peter, Griffith, Malachi, Danos, Arpad M., Pitel, Beth A., Madhavan, Subha, Liu, Xuelu, Chow, Cynthia, Williams, Heather, Carmody, Leigh, Barrow-Laing, Lisa, Rieke, Damian, Kreutzfeldt, Simon, Stenzinger, Albrecht, Tamborero, David, Benary, Manuela, Rajagopal, Padma Sheila, Ida, Cristiane M., Lesmana, Harry, Satgunaseelan, Laveniya, Merker, Jason D., Tolstorukov, Michael Y., Campregher, Paulo Vidal, Warner, Jeremy L., Rao, Shruti, Natesan, Maya, Shen, Haolin, Venstrom, Jeffrey, Roy, Somak, Tao, Kayoko, Kanagal-Shamanna, Rashmi, Xu, Xinjie, Ritter, Deborah I., Pagel, Kym, Krysiak, Kilannin, Dubuc, Adrian, Akkari, Yassmine M., Li, Xuan Shirley, Lee, Jennifer, King, Ian, Raca, Gordana, Wagner, Alex H., Li, Marylin M., Plon, Sharon E., Kulkarni, Shashikant, Griffith, Obi L., Chakravarty, Debyani, Sonkin, Dmitriy

Source: In Genetics in Medicine May 2022 24(5):986-998

The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer

Authors: Jin, Will H., Zhang, Liangliang, Graf, Ryon, Raskina, Kira, Tukachinsky, Hanna, Huang, Richard S.P., McGregor, Kimberly, Alshalalfa, Mohamed, Hougen, Helen Y., Khan, Anwar, Punnen, Sanoj, Schrock, Alexa B., Venstrom, Jeffrey, Mahal, Brandon A.

Source: In Clinical Genitourinary Cancer February 2024 22(1):e163-e169

Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary

Authors: Lin, Douglas I., Killian, Jonathan K., Venstrom, Jeffrey M., Ramkissoon, Shakti H., Ross, Jeffrey S., Elvin, Julia A.

Source: In Modern Pathology May 2021 34(5):983-993

A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases

Authors: Huang, Richard S.P., Haberberger, James, Severson, Eric, Duncan, Daniel L., Hemmerich, Amanda, Edgerly, Claire, Ferguson, Naomi Lynn, Williams, Erik, Elvin, Julia, Vergilio, Jo-Anne, Killian, Jonathan Keith, Lin, Douglas I., Tse, Julie, Hiemenz, Matthew, Owens, Clarence, Danziger, Natalie, Hegde, Priti S., Venstrom, Jeffrey, Alexander, Brian, Ross, Jeffrey S., Ramkissoon, Shakti H.

Source: In Modern Pathology February 2021 34(2):252-263

RAS Amplification as a Negative Predictor of Benefit from Anti‐EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer

Authors: Schrock, Alexa B., Lee, Jessica K., Sandhu, Jaideep, Madison, Russell, Cho‐Phan, Cheryl, Snider, Jeremy W., Castellanos, Emily, Venstrom, Jeffrey M., Fakih, Marwan

Source: Oncologist. 26(6):469-475

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121457957.0x000001&indx=1&recIds=ETOCvdc_100121457957.0x000001

Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases

Authors: Huang, Richard S. P., Haberberger, James, Sokol, Ethan, Schrock, Alexa B., Danziger, Natalie, Madison, Russell, Trabucco, Sally, Jin, Dexter, Pavlick, Dean, Ramanan, Vivek, Hole, Kanchan, McGregor, Kimberly, Venstrom, Jeffrey, Ross, Jeffrey S.

Source: International journal of cancer. 148(7):1778-1788

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116948926.0x000001&indx=1&recIds=ETOCvdc_100116948926.0x000001

Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer

Authors: Stein, Stacey M, Snider, Jeremy, Ali, Siraj M, Miksad, Rebecca A, Alexander, Brian M, Castellanos, Emily, Schrock, Alexa B, Madison, Russell, Swaminathan, Akshay, Venstrom, Jeffrey M, McCusker, Margaret

Source: Future oncology. 17(31):4101-4114

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187771467.0x000001&indx=1&recIds=ETOCvdc_100187771467.0x000001

Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing

Authors: Trabucco, Sally E, Sokol, Ethan S, Maund, Sophia L, Moore, Jay A, Frampton, Garrett M, Albacker, Lee A, Oestergaard, Mikkel Z, Venstrom, Jeffrey, Sehn, Laurie H, Bolen, Christopher R

Source: Future oncology. 17(31):4171-4183

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187771315.0x000001&indx=1&recIds=ETOCvdc_100187771315.0x000001

Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma

Authors: Bolen, Christopher R., Mattiello, Federico, Herold, Michael, Hiddemann, Wolfgang, Huet, Sarah, Klapper, Wolfram, Marcus, Robert, Mir, Farheen, Salles, Gilles, Weigert, Oliver, Nielsen, Tina, Oestergaard, Mikkel Z., Venstrom, Jeffrey M.

Source: Blood. 137(19):2704-2707

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183251832.0x000001&indx=1&recIds=ETOCvdc_100183251832.0x000001

Evaluation of the effect of prospective biomarker testing on progression-free survival in diffuse large B-cell lymphoma

Authors: Szafer-Glusman, Edith, Liu, Juan, Sinha, Arijit, Peale, Franklin V., Ray, Jill, Horn, Carsten, Oestergaard, Mikkel Z., Kornacker, Martin, Sehn, Laurie H., Vitolo, Umberto, Knapp, Andrea, Venstrom, Jeffrey, Byrtek, Michelle, Punnoose, Elizabeth

Source: Leukemia & lymphoma. 62(4):999-1002

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100117673802.0x000001&indx=1&recIds=ETOCvdc_100117673802.0x000001

Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer

Authors: Necchi, Andrea, Cucchiara, Vito, Grivas, Petros, Bratslavsky, Gennady, Jacob, Joseph, Spiess, Philippe E., Sokol, Ethan S., Killian, Jonathan Keith, Lin, Douglas, Ramkissoon, Shakti, Huang, Richard S. P., Madison, Russell W., Venstrom, Jeffrey M., Schrock, Alexa B., Danziger, Natalie, Decker, Brennan, Gjoerup, Ole, Graf, Ryon P., Oxnard, Geoffrey R., Tukachinsky, Hanna, Ross, Jeffrey S.

Source: Cancer. 127(24):4557-4564

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157759760.0x000001&indx=1&recIds=ETOCvdc_100157759760.0x000001

Clinicopathologic and Genomic Characterization of PD‐L1 Positive Urothelial Carcinomas

Authors: Huang, Richard S.P., Haberberger, James, Harries, Lukas, Severson, Eric, Duncan, Daniel L., Ferguson, N. Lynn, Hemmerich, Amanda, Edgerly, Claire, Murugesan, Karthikeyan, Xiao, Jinpeng, McEwan, Deborah, Holmes, Oliver, Hiemenz, Matthew, Venstrom, Jeffrey, Elvin, Julia A., Creeden, James, Lin, Douglas I., Ross, Jeffrey S., Ramkissoon, Shakti H.

Source: Oncologist. 26(5):375-382

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121317316.0x000001&indx=1&recIds=ETOCvdc_100121317316.0x000001

A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease.

Authors: Mahal, Brandon A., Margolis, Matthew, Hubbell, Earl, Chen, Cheng, Venstrom, Jeffrey M., Abran, John, Karlitz, Jordan J., Wyatt, Alexander W., Klein, Eric A.

Source: JCO Precision Oncology; 12/1/2024, Vol. 8, p1-8, 8p

Subject Terms: OVERALL survival, BLOOD testing, OVERDIAGNOSIS, ADULTS, PROSTATE cancer, GENOMES

Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling

Authors: Madison, Russell ^*, Schrock, Alexa B., Castellanos, Emily, Gregg, Jeffrey P., Snider, Jeremy, Ali, Siraj M., Miller, Vincent A., Singal, Gaurav, Alexander, Brian M., Venstrom, Jeffrey M., Chung, Jon H.

Source: In Lung Cancer October 2020 148:69-78

Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis

Authors: Alshalalfa, Mohammed, Nguyen, Tiffany T., Stopsack, Konrad H., Khan, Anwar, Franco, Idalid, Seldon, Crystal, Swami, Nishwant, Jin, William, Meiyappan, Karthik, Ton, Minh, Venstrom, Jeffrey M., Dee, Edward Christopher, Mahal, Brandon A.

Source: Urologic oncology. 41(2):106.e17-106.e23

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181219285.0x000001&indx=1&recIds=ETOCvdc_100181219285.0x000001

Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD‐L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer

Authors: Huang, Richard S.P., Li, Xinyan, Haberberger, James, Sokol, Ethan, Severson, Eric, Duncan, Daniel L., Hemmerich, Amanda, Edgerly, Claire, Williams, Erik, Elvin, Julia, Vergilio, Jo‐Anne, Killian, Jonathan Keith, Lin, Douglas, Hiemenz, Matthew, Xiao, Jinpeng, McEwan, Deborah, Holmes, Oliver, Danziger, Natalie, Erlich, Rachel, Frampton, Garrett, Cohen, Michael B., McGregor, Kimberly, Reddy, Prasanth, Cardeiro, Dawn, Anhorn, Rachel, Venstrom, Jeffrey, Alexander, Brian, Brown, Charlotte, Pusztai, Lajos, Ross, Jeffrey S., Ramkissoon, Shakti H.

Source: Oncologist. 25(11):943-953

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100109216678.0x000001&indx=1&recIds=ETOCvdc_100109216678.0x000001

Evidence‐Based Development and Clinical Use of Precision Oncology Therapeutics

Authors: Comment, Leah A., Ward, Ashley F., Schrock, Alexa B., Fabrizio, David, Venstrom, Jeffrey M., Hegde, Priti S., Alexander, Brian M.

Source: Clinical pharmacology & therapeutics. 108(3):440-443

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100108113584.0x000001&indx=1&recIds=ETOCvdc_100108113584.0x000001